CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Sheridan, Graham K ^a,b   Wdowicz, Anita ^a   Pickering, Mark ^a   Watters, Orla ^a   Halley, Paul ^a   O'Sullivan, Niamh C ^a   Mooney, Claire ^a   O'Connell, David J ^a   O'Connor, John J ^a   Murphy, Keith J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Calcium imaging; Chemokine signaling; Fractalkine; Learning and memory; Ltp; Water maze

Indexed keywords

EID: 84905977565     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00233     Document Type: Article

References (106)

1. Adler, M. W., Geller, E. B., Chen, X., and Rogers, T. J. (2006). Viewing chemokines as a third major system of communication in the brain. AAPS J. 7, E865-E870. doi: 10.1208/aapsj070484
2. Adler, M. W., and Rogers, T. J. (2005). Are chemokines the third major system in the brain? J. Leukoc. Biol. 78, 1204-1209. doi: 10.1189/jlb.0405222
3. Allen, S. J., Crown, S. E., and Handel, T. M. (2007). Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25, 787-820. doi: 10.1146/annurev.immunol.24.021605.090529
4. Antonucci, F., Alpár, A., Kacza, J., Caleo, M., Verderio, C., Giani, A., et al. (2012). Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks. J. Neurosci. 32, 1989-2001. doi: 10.1523/JNEUROSCI.2720-11.2012
5. Araujo, D. M., and Cotman, C. W. (1993). Trophic effects of interleukin-4, -7, and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600, 49-55. doi: 10.1016/0006-8993(93)90400-H
6. Arima-Yoshida, F., Watabe, A. M., and Manabe, T. (2011). The mechanisms of the strong inhibitory modulation of long-term potentiation in the rat dentate gyrus. Eur. J. Neurosci. 33, 1637-1646. doi: 10.1111/j.1460-9568.2011.07657.x
7. Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., et al. (2011). Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32, 2030-2044. doi: 10.1016/j.neurobiolaging.2009.11.022
8. Baier, P. C., May, U., Scheller, J., Rose-John, S., and Schiffelholz, T. (2009). Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav. Brain Res. 200, 192-196. doi: 10.1016/j.bbr.2009.01.013
9. Balschun, D., Wetzel, W., Del Rey, A., Pitossi, F., Schneider, H., Zuschratter, W., et al. (2004). Interleukin-6: a cytokine to forget. FASEB J. 18, 1788-1790. doi: 10.1096/fj.04-1625fje
10. Bast, T. (2011). The hippocampal learning-behavior translation and the functional significance of hippocampal dysfunction in schizophrenia. Curr. Opin. Neurobiol. 21, 492-501. doi: 10.1016/j.conb.2011.01.003
11. Ben Menachem-Zidon, O., Avital, A., Ben-Menahem, Y., Goshen, I., Kreisel, T., Shmueli, E. M., et al. (2011). Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling. Brain Behav. Immun. 25, 1008-1016. doi: 10.1016/j.bbi.2010.11.007
12. 3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51, 816-821. doi: 10.1016/j.neuropharm.2006.05.027
13. Bliss, T. V. P., and Collingridge, G. L. (1993). A synaptic model of memory: long term potentiation and the hippocampus. Nature 361, 31-39. doi: 10.1038/361031a0
14. Briones, T. L., Woods, J., and Wadowska, M. (2014). Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling. J. Neuroinflammation 11:13. doi: 10.1186/1742-2094-11-13
15. Bruel-Jungerman, E., Davis, S., and Laroche, S. (2007a). Brain plasticity mechanisms and memory: a party of four. Neuroscientist 13, 492-505. doi: 10.1177/1073858407302725
16. Bruel-Jungerman, E., Rampon, C., and Laroche, S. (2007b). Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses. Rev. Neurosci. 18, 93-114. doi: 10.1515/REVNEURO.2007.18.2.93
17. Bruno, V., Copani, A., Besong, G., Scoto, G., and Nicoletti, F. (2000). Neuroprotective activity of chemokines against N -methyl-D-aspartate or betaamyloid-induced toxicity in culture. Eur. J. Pharmacol. 399, 117-121. doi: 10.1016/S0014-2999(00)00367-8
18. Cambien, B., Pomeranz, M., Schmid-Antomarchi, H., Millet, M. A., Breittmayer, V., Rossi, B., et al. (2001). Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood 97, 2031-2037. doi: 10.1182/blood.V97.7.2031
19. Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., et al. (2006). Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924. doi: 10.1038/nn1715
20. 3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes. J. Neuroimmunol. 263, 75-82. doi: 10.1016/j.jneuroim.2013.07.020
21. Chapman, G. A., Moores, K., Harrison, D., Campbell, C. A., Stewart, B. R., and Strijbos, P. J. (2000). Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20:RC87.
22. 3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 31, 16327-16335. doi: 10.1523/JNEUROSCI.3611-11.2011
23. Clark, A. K., Yip, P. K., Grist, J., Gentry, C., Staniland, A. A., Marchand, F., et al. (2007). Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U.S.A. 104, 10655-10660. doi: 10.1073/pnas.0610811104
24. Coogan, A. N., O'Neill, L. A., and O'Connor, J. J. (1999). The P38 mitogenactivated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93, 57-69. doi: 10.1016/S0306-4522(99)00100-1
25. 3CL1 homeostasis by SDF/CXCL12 in cortical neurons. J. Biol. Chem. 285, 10563-10571. doi: 10.1074/jbc.M109.035477
26. Deiva, K., Geeraerts, T., Salim, H., Leclerc, P., Héry, C., Hugel, B., et al. (2004). Fractalkine reduces N -methyl-D-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur. J. Neurosci. 20, 3222-3232. doi: 10.1111/j.1460-9568.2004.03800.x
27. del Rey, A., Balschun, D., Wetzel, W., Randolf, A., and Besedovsky, H. O. (2013). A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav. Immun. 33, 15-23. doi: 10.1016/j.bbi.2013.05.011
28. Erichsen, D., Lopez, A. L., Peng, H., Niemann, D., Williams, C., Bauer, M., et al. (2003). Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J. Neuroimmunol. 138, 144-155. doi: 10.1016/S0165-5728(03)00117-6
29. 3CL1). J. Biol. Chem. 276, 37993-38001. doi: 10.1074/jbc.M106434200
30. Gemma, C., and Bachstetter, A. D. (2013). The role of microglia in adult hippocampal neurogenesis. Front. Cell. Neurosci. 7:229. doi: 10.3389/fncel.2013.00229
31. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., et al. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U.S.A. 95, 10896-10901. doi: 10.1073/pnas.95.18.10896
32. Hatori, K., Nagai, A., Heisel, R., Ryu, J. K., and Kim, S. U. (2002). Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69, 418-426. doi: 10.1002/jnr.10304
33. 3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 164, 1210-1223. doi: 10.1016/j.neuroscience.2009.08.075
34. Hopkins, S. J., and Rothwell, N. J. (1995). Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci. 18, 83-88. doi: 10.1016/0166-2236(95)80029-2
35. Hoshiko, M., Arnoux, I., Avignone, E., Yamamoto, N., and Audinat, E. (2012). Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J. Neurosci. 32, 15106-15111. doi: 10.1523/JNEUROSCI.1167-12.2012
36. 3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37, 314-327. doi: 10.1002/glia.10037
37. 3CL1-mediated cell-cell adhesion. Blood 102, 1186-1195. doi: 10.1182/blood-2002-12-3775
38. Hunsaker, M. R., and Kesner, R. P. (2008). Evaluating the differential roles of the dorsal dentate gyrus, dorsal CA3, and dorsal CA1 during a temporal ordering for spatial locations task. Hippocampus 18, 955-964. doi: 10.1002/hipo.20455
39. Jankowsky, J. L., Derrick, B. E., and Patterson, P. H. (2000). Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn. Mem. 7, 400-412. doi: 10.1101/lm.32600
40. 3CL1 in rheumatoid arthritis. Arthritis Rheum. 65, 2814-2825. doi: 10.1002/art.38095
41. Jovanovic, J. N., Thomas, P., Kittler, J. T., Smart, T. G., and Moss, S. J. (2004). Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABAA receptor phosphorylation, activity, and cell-surface stability. J. Neurosci. 24, 522-530. doi: 10.1523/JNEUROSCI.3606-03.2004
42. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., et al. (2000). Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106-4114. doi: 10.1128/MCB.20.11.4106-4114.2000
43. Katz, L. C., and Shatz, C. J. (1996). Synaptic activity and the construction of cortical circuits. Science 274, 1133-1138. doi: 10.1126/science.274.5290.1133
44. Klosowska, K., Volin, M. V., Huynh, N., Chong, K. K., Halloran, M. M., and Woods, J. M. (2009). Fractalkine functions as a chemoattractant for osteoarthritis synovial fibroblasts and stimulates phosphorylation of mitogenactivated protein kinases and Akt. Clin. Exp. Immunol. 156, 312-319. doi: 10.1111/j.1365-2249.2009.03903.x
45. Komuro, H., and Rakic, O. (1998). Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations. J. Neurobiol. 37, 110-130. doi: 10.1002/(SICI)1097-4695(199810)37:13.3.CO;2-Q
46. Krathwohl, M. D., and Kaiser, J. L. (2004). Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109-118. doi: 10.1634/stemcells.22-1-109
47. 3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 35, 1550-1559. doi: 10.1038/npp.2010.26
48. Li, A. J., Katafuchi, T., Oda, S., Hori, T., and Oomura, Y. (1997). Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748, 30-38. doi: 10.1016/S0006-308993(96)01283-8
49. Limatola, C., Ciotti, M. T., Mercanti, D., Vacca, F., Ragozzino, D., Giovannelli, A., et al. (2000). The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 6197-6201. doi: 10.1073/pnas.090105997
50. 3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 166, 19-28. doi: 10.1016/j.jneuroim.2005.03.023
51. Lu, M., Grove, E. A., and Miller, R. J. (2002). Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. U.S.A. 99, 7090-7095. doi: 10.1073/pnas.092013799
52. Lyons, A., Lynch, M. A, Downer, J. E., Hanley, R., O'Sullivan, B. J, Smith, A., et al. (2009). Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro. J. Neurochem. 110, 1547-1556. doi: 10.1111/j.1471-4159.2009.06253
53. Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R., and Bacon, K. B. (1999). Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR1-expressing microglia. J. Immunol. 163, 1628-1635.
54. Maggi, L., Scianni, M., Branchi, I., D'Andrea, I., Lauro, C., and Limatola, C. (2011). CX3CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front. Cell. Neurosci. 5:1-10. doi: 10.3389/fncel.2011.00022
55. 3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J. Neuroimmunol. 215, 36-42. doi: 10.1016/j.jneuroim.2009.07.016
56. Malenka, R. C., and Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21. doi: 10.1016/j.neuron.2004.09.012
57. Mattison, H. A., Nie, H., Gao, H., Zhou, H., Hong, J. S., and Zhang, J. (2013). Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice. J. Neuroimmunol. 257, 110-115. doi: 10.1016/j.jneuroim.2013.02.008
58. McAfoose, J., and Baune, B. T. (2009). Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 33, 355-366. doi: 10.1016/j.neubiorev.2008.10.005
59. Meltzer, H. Y. (1990). Role of serotonin in depression. Ann. N. Y. Acad. Sci. 600, 486-499. doi: 10.1111/j.1749-6632.1990.tb16904.x
60. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., and Miller, R. J. (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 14500-14505. doi: 10.1073/pnas.95.24.14500
61. Meucci, O., Fatatis, A., Simen, A. A., and Miller, R. J. (2000). Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 97, 8075-8080. doi: 10.1073/pnas.090017497
62. Mizoguchi, Y., Kanematsu, T., Hirata, M., and Nabekura, J. (2003). A rapid increase in the total number of cell surface functional GABAA receptors induced by brainderived neurotrophic factor in rat visual cortex. J. Biol. Chem. 278, 44097-44102. doi: 10.1074/jbc.M305872200
63. Nusser, Z., Hajos, N., Somogyi, P., and Mody, I. (1998). Increased number of synaptic GABAA receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395, 172-177. doi: 10.1038/25999
64. Oh, S. B., Endoh, T., Simen, A. A., Ren, D., and Miller, R. J. (2002). Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 123, 66-75. doi: 10.1016/S0165-5728(01)00485-4
65. Old, E. A., and Malcangio, M. (2012). Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states. Curr. Opin. Pharmacol. 12, 67-73. doi: 10.1016/j.coph.2011.10.015
66. 3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 8:9. doi: 10.1186/1742-2094-8-9
67. Pau, G., Fuchs, F., Sklyar, O., Boutros, M., and Huber, W. (2010). EBImage an R package for image processing with applications to cellular phenotypes. Bioinformatics 26, 979-981. doi: 10.1093/bioinformatics/btq046
68. th Edn. San Diego, CA: Elsevier Academic Press.
69. 3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. J. Neuroimmunol. 27, 85-92. doi: 10.1016/j.jneuroim.2010.05.012
70. Pickering, M., Pickering, B. W., Murphy, K. J., and O'Connor, J. J. (2008). Discrimination of cell types in mixed cortical culture using calcium imaging: a comparison to immunocytochemical labeling. J. Neurosci. Methods 173, 27-33. doi: 10.1016/j.jneumeth.2008.05.014
71. Pollmächer, T., Haack, M., Schuld, A., Reichenberg, A., and Yirmiya, R. (2002). Low levels of circulating inflammatory cytokines do they affect human brain functions? Brain Behav. Immun. 16, 525-532. doi: 10.1016/S0889-1591(02)00004-1
72. 3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 26, 10488-10498. doi: 10.1523/JNEUROSCI.3192-06.2006
73. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., et al. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58, 445-452. doi: 10.1001/archpsyc.58.5.445
74. Robinson, S., Tani, M., Strieter, R. M., Ransohoff, R. M., and Miller, R. H. (1998). The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18, 10457-10463.
75. Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., et al. (2011). CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31, 16241-16250. doi: 10.1523/JNEUROSCI.3667-11.2011
76. Rolls, E. T. (2010). A computational theory of episodic memory formation in the hippocampus. Behav. Brain Res. 215, 180-196. doi: 10.1016/j.bbr.2010.03.027
77. 3CL1 modulates GABAA currents in human temporal lobe epilepsy. Epilepsia 54, 1834-1844. doi: 10.1111/epi.12354
78. Ross, F. M., Allan, S. M., Rothwell, N. J., and Verkhratsky, A. (2003). A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 144, 61-67. doi: 10.1016/j.jneuroim.2003.08.030
79. Rostene, W., Kitabgi, P., and Parsadaniantz, S. M. (2007). Chemokines: a new class of neuromodulator? Nat. Rev. Neurosci. 8, 895-903. doi: 10.1038/nrn2255
80. Rothwell, N. J., and Hopkins, S. J. (1995). Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 8, 130-136. doi: 10.1016/0166-2236(95)93890-A
81. 3CL1 in the hypothalamic paraventricular nucleus are attenuated in rats with heart failure. Exp. Physiol. 99, 111-122. doi: 10.1113/expphysiol.2013.075432
82. Ruchaya, P. J., Paton, J. F., Murphy, D., and Yao, S. T. (2012). A cardiovascular role for fractalkine and its cognate receptor, CX3CR1, in the rat nucleus of the solitary tract. Neuroscience 209, 119-127. doi: 10.1016/j.neuroscience.2012.02.018
83. Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., and Besedovsky, H. O. (1998). A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 95, 7778-7783. doi: 10.1073/pnas.95.13.7778
84. 3CL1) enhances hippocampal N -methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J. Neuroinflammation 10, 108. doi: 10.1186/1742-2094-10-108
85. Shepherd, A. J., Loo, L., and Mohapatra, D. P. (2013). Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure. PLoS ONE 8:e76698. doi: 10.1371/journal.pone.0076698
86. Sheridan, G. K., and Murphy, K. J. (2013). Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol. 3:130181. doi: 10.1098/rsob.130181
87. Small, S. A., Schobel, S. A., Buxton, R. B., Witter, M. P., and Barnes, C. A. (2011). A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 12, 585-601. doi: 10.1038/nrn3085
88. Spitzer, N. C., Lautermilch, N. J., Smith, R. D., and Gomez, T. M. (2000). Coding of neuronal differentiation by calcium transients. Bioessays 22, 811-817. doi: 10.1002/1521-1878(200009)22:9<811::AID-BIES6>3.0.CO;2-G
89. Stoppini, L., Buchs, P. A., and Muller, D. (1991). A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182. doi: 10.1016/0165-0270(91)90128-M
90. Tarozzo, G., Bortolazzi, S., Crochemore, C., Chen, S. C., Lira, A. S., Abrams, J. S., et al. (2003). Fractalkine protein localization and gene expression in mouse brain. J. Neurosci. Res. 73, 81-88. doi: 10.1002/jnr.10645
91. Tarozzo, G., Campanella, M., Ghiani, M., Bulfone, A., and Beltramo, M. (2002). Expression of fractalkine and its receptor, CX3CR1, in response to ischaemiareperfusion brain injury in the rat. Eur. J. Neurosci. 15, 1663-1668. doi: 10.1046/j.1460-9568.2002.02007.x
92. Tong, N., Perry, S. W., Zhang, Q., James, H. J., Guo, H., Brooks, A., et al. (2000). Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 164, 1333-1339. doi: 10.4049/jimmunol.164.3.1333
93. Tran, P. B., and Miller, R. J. (2003). Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4, 444-455. doi: 10.1038/nrn1116
94. Tsou, C. L., Haskell, C. A., and Charo, I. F. (2001). Tumor necrosis factor-alphaconverting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 276, 44622-44626. doi: 10.1074/jbc.M107327200
95. Turrigiano, G. (2007). Homeostatic signaling: the positive side of negative feedback. Curr. Opin. Neurobiol. 17, 318-324. doi: 10.1016/j.conb.2007.04.004
96. Turrigiano, G. G. (2008). The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135, 422-435. doi: 10.1016/j.cell.2008.10.008
97. 3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20, 1150-1160. doi: 10.1111/j.1460-9568.2004.03593.x
98. Wan, Q., Xiong, Z. G., Man, H. Y., Ackerley, C. A., Braunton, J., Lu, W. Y., et al. (1997). Recruitment of functional GABAA receptors to postsynaptic domains by insulin. Nature 388, 686-690. doi: 10.1038/41792
99. Wang, Q., Liu, L., Pei, L., Ju, W., Ahmadian, G., Lu, J., et al. (2003). Control of synaptic strength, a novel function of Akt. Neuron 38, 915-928. doi: 10.1016/S0896-6273(03)00356-8
100. White, G. E., and Greaves, D. R. (2012). Fractalkine: a survivor's guide: chemokines as anti-apoptotic mediators. Arterioscler. Thromb. Vasc. Biol. 32, 589-594. doi: 10.1161/ATVBAHA.111.237412
101. Williamson, L. L., and Bilbo, S. D. (2013). Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability. Brain Behav. Immun. 30, 186-194. doi: 10.1016/j.bbi.2013.01.077
102. Wilson, C. J., Finch, C. E., and Cohen, H. J. (2002). Cytokines and cognition the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 50, 2041-2056. doi: 10.1046/j.1532-5415.2002.50619.x
103. Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., and Naguibemail, M. (2013). Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol. Aging 34, 2843-2852. doi: 10.1016/j.neurobiolaging.2013.06.003
104. Yeo, S. I., Kim, J. E., Ryu, H. J., Seo, C. H., Lee, B. C., Choi, I. G., et al. (2011). The roles of fractalkine/CX3CR1 system in neuronal death following pilocarpine-induced status epilepticus. J. Neuroimmunol. 234, 93-102. doi: 10.1016/j.jneuroim.2011.03.005
105. Yirmiya, R., and Goshen, I. (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25, 181-213. doi: 10.1016/j.bbi.2010.10.015
106. Zhuang, Z. Y., Kawasaki, Y., Tan, P. H., Wen, Y. R., Huang, J., and Ji, R. R. (2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun. 21, 642-651. doi: 10.1016/j.bbi.2006.11.003